دورية أكاديمية

Selective serotonin reuptake inhibitors (SSRIs) in pregnancy: a review.

التفاصيل البيبلوغرافية
العنوان: Selective serotonin reuptake inhibitors (SSRIs) in pregnancy: a review.
المؤلفون: Fleschler R, Peskin MF
المصدر: MCN: The American Journal of Maternal Child Nursing; Nov/Dec2008, Vol. 33 Issue 6, p355-363, 9p
مستخلص: Major affective disorders including depression and anxiety occur commonly in women of childbearing age and their incidence can increase during and after pregnancy. There is a critical clinical demand for treatment of these disorders, but the balance between treating affective disorders without harming the developing fetus is a difficult one. This has created concern both among women planning pregnancies, and those women who are pregnant already, as well as among families and healthcare providers. Currently, selective serotonin reuptake inhibitors (SSRIs) are the drugs of choice for the treatment of these disorders in pregnant women because of their documented efficacy and mild side effect profile. There is some research concerning SSRI use and pregnancy, which is the focus of this article. [ABSTRACT FROM AUTHOR]
Copyright of MCN: The American Journal of Maternal Child Nursing is the property of Lippincott Williams & Wilkins and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Supplemental Index
الوصف
تدمد:0361929X
DOI:10.1097/01.nmc.0000341255.80426.7b